跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,470 条关于
“tumor-associated hyperinsulinism”
全部
44,470
临床试验
28,085
药物
918
机构
173
资讯
15,294
9个月前
Rezolute's Ersodetug Fails Phase 3 Trial for Congenital Hyperinsulinism, Stock Plunges 88%
2年前
FDA Lifts Clinical Hold on Rezolute's Ersodetug for Congenital Hyperinsulinism, Allowing US Trial Enrollment
去年
Engineered Microparticles Repolarize Tumor-Associated Macrophages and Inhibit Colorectal Cancer Progression
去年
Histone Modifications Drive Tumor-Associated Macrophage Polarization in Cancer Immunotherapy
去年
Ersodetug Receives FDA Orphan Drug Designation for Tumor-Induced Hypoglycemia
9个月前
Tumor-Associated Macrophages Drive Gastric Cancer Progression Through Immune Evasion and Therapeutic Resistance
去年
Ersodetug Receives FDA Breakthrough Therapy Designation for Congenital Hyperinsulinism
去年
Sidra Medicine Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism
去年
CD163+ Tumor-Associated Macrophages Linked to Improved Nivolumab Outcomes in Metastatic Renal Cell Carcinoma
去年
Congenital Hyperinsulinism Pipeline Shows Promise with Multiple Therapies Advancing Through Clinical Development
第 1 页，共 1530 页
上一页
下一页
